W
2.99
-0.18 (-5.68%)
| Previous Close | 3.17 |
| Volume | 68,192 |
| Price / Book | 0.960 |
| 52 Weeks Range |
| Profit Margin | 99.42% |
| Operating Margin (TTM) | -212.99% |
| Diluted EPS (TTM) | 0.150 |
| Quarterly Revenue Growth (YOY) | 33.50% |
| Total Debt/Equity (MRQ) | 1.59% |
| Current Ratio (MRQ) | 18.95 |
| Operating Cash Flow (TTM) | -51.76 M |
| Levered Free Cash Flow (TTM) | -24.65 M |
| Return on Assets (TTM) | -21.92% |
| Return on Equity (TTM) | 17.69% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Whitehawk Therapeutics, Inc. | Mixed | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -0.2 |
| Technical Moving Averages | -1.5 |
| Technical Oscillators | -2.5 |
| Relative Valuation | NA |
| Financial Health | -5.0 |
| Macro Environment | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | -1.45 |
Select this tab to load the latest available analysis.
|
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 12.44% |
| % Held by Institutions | 67.64% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Yu Fan | 30 Jun 2026 | 4,861,314 |
| Acuta Capital Partners, Llc | 30 Jun 2026 | 4,685,912 |
| Qvt Financial Lp | 30 Jun 2026 | 4,615,709 |
| Montanova Capital, Llc | 30 Jun 2026 | 4,300,000 |
| Orbimed Advisors Llc | 30 Jun 2026 | 3,934,296 |
| Avoro Capital Advisors Llc | 30 Jun 2026 | 2,849,402 |
| Siren, L.L.C. | 30 Jun 2026 | 2,337,102 |
| Kvp Capital Advisors, Lp | 30 Jun 2026 | 2,165,997 |
| Acorn Capital Advisors, Llc | 30 Jun 2026 | 1,139,363 |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |